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ABSTRACT
FpgisaDNAglycosylasethatrecognizesandexcises
the mutagenic 8-oxoguanine (8-oxoG) and the poten-
tially lethal formamidopyrimidic residues (Fapy). Fpg
is also associated with an AP lyase activity which
successively cleaves the abasic (AP) site at the 30
and 50 sides by bd-elimination. Here, we present the
high-resolutioncrystalstructuresofthewild-typeand
the P1G defective mutant of Fpg from Lactococcus
lactisboundto14merDNAduplexescontainingeither
atetrahydrofuran(THF)or1,3-propanediol(Pr)APsite
analogues. Structures show that THF is less extra-
helicalthanPranditsbackboneC50–C40–C30 diverges
significantly from those of Pr, rAP, 8-oxodG and
FapydG. Clearly, the heterocyclic oxygen of THF is
pushed back by the carboxylate of the strictly
conserved E2 residue. We can propose that the
ring-opened form of the damaged deoxyribose is
thestructureactiveformofthesugarforFpgcatalysis
process. Both structural and functional data sug-
gest that the first step of catalysis mediated by Fpg
involves the expulsion of the O40 leaving group
facilitated by general acid catalysis (involving E2),
rather than the immediate cleavage of the N-glycosic
bond of the damaged nucleoside.
INTRODUCTION
Cellular DNA is continuously subjected to damaging agents
from endogenous or exogenous origin (1). To prevent the
deleterious effect of such damage (mutagenesis, diseases and
celldeath),allorganismsstudiedtodatehaveevolvedavariety
of DNA repair processes speciﬁc of the type of DNA damage
(2,3). The modiﬁcations of the heterocyclic DNA base that
are caused by agents involved in normal cellular metabolism
resulting in oxidation, alkylation, deamination or base loss
[formation of an abasic site, (AP)] are principally addressed
by the base excision repair pathway (BER) (4). The DNA
glycosylases, the key enzymes of the BER pathway, specif-
ically recognize and excise the damaged base (DNA glyco-
sylase activity) leading to the formation of an AP site in DNA.
Among these enzymes, some of them are bifunctional and
associated with an AP lyase activity able to cleave at the
30 side the AP site by a b-elimination mechanism. The
30-pre-incised AP site is then eliminated by a cleavage at
its 50 side by an AP endonuclease resulting in the formation
of a 1 nt gap in DNA. Finally, DNA repair is achieved by the
successive action of a DNA polymerase to ﬁll in the gap and
a DNA ligase to close up the repaired DNA strand.
Fpg (formamidopyrimidine–DNA glycosylase) is a bac-
terial DNA glycosylase/AP lyase enzyme involved in the
repair of oxidized purines, such as 8-oxoguanine (8-oxoG)
and imidazole-ring opened purines (FapyG, FapyA) (5–9).
The enzyme eliminates the AP site by successive cleavage
at its 30 and 50 sides by a bd-elimination reaction (10,11).
Fpg achieves its catalytic process using its P1 N-terminal
amino group to perform a nucleophilic attack at the C10 of
the damaged nucleoside. During this process, the enzyme
forms an imino enzyme–DNA intermediate which can be sta-
bilized irreversibly by sodium borohydryde (12). Through its
activities, Fpg counteracts the mutagenic effects of 8-oxoG
and the AP site all together associated with G/T transversions
and of the lethal potential of the Fapy residues which con-
stitute DNA polymerase blocks, in vitro (8,9,13–15). As
revealed by X-ray crystallographic studies of Fpg bound to
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doi:10.1093/nar/gki879a damage-containing DNA, Fpg gains access to its substrate
nucleoside by extruding it from the DNA helix (16–20).
The resulting extrahelical damaged nucleoside is then inserted
into a substrate binding pocket of the enzyme and exposes
its C10 to the nucleophilic attack of the amino group of the P1
N-terminal residue.
During the past decade, our understanding of the damaged
DNA recognition by Fpg has advanced greatly. Structural,
chemical and biochemical studies of Fpg interacting with
DNA have led to depict the mechanisms underlying of the
damaged nucleoside recognition. Two general approaches
have been used so far to generate stable abortive Fpg/DNA
complexes enabling to study at the molecular level the inter-
action of this enzyme with its substrates, reaction intermediate
and products. One of these relies on site-directed mutagenesis
of the active site residues to abolish catalysis, independently
from the Fpg speciﬁc DNA binding (19). An alternative
approach relies on the design and synthesis of uncleavable
substrate analogues or inhibitors. One class of inhibitors
recently consists of nucleobase analogues with a stabilized
N-glycosydic bond, that are not processed by Fpg (21,22).
The second class of inhibitors more extensively used for
Fpg and other AP lyases contains cyclic and non cyclic AP
site analogues that mimic the AP site structure in the catalytic
transition state, preventing the Fpg end products synthesis
(Figure 1) (23–25). We have employed both strategies to
investigate the structural and/or functional determinants of
the damaged nucleoside for Fpg speciﬁc recognition
(16,20,26). In this work, we propose a comparative structural
analysis of wild-type and mutant Fpg proteins bound to cyclic
and non-cyclic AP site analogues containing DNA. The
present four new crystal structures of Fpg/DNA complexes
unfavour the recognition of the hemiacetal form of the AP
site (Figure 1).
MATERIALS AND METHODS
DNA and proteins
Self-complementary 14mer single-stranded oligonucleotides
were purchased from Eurogentec (Belgium). After puriﬁcation
according to the procedure described by Pereira et al. (26),
they were annealed with their complementary strand to gen-
erate blunt- or sticky-ended DNA duplexes containing an AP
site analogue, 1,3-propanediol (Pr) or tetrahydrofuran (THF),
at position 7 or 8. The 12 DNA duplexes (listed in Table 1)
used in this study have nucleotide sequences on each side
of the target site similar to those previously used (16,26).
Wild-type LlFpg (W) and mutant P1G-LlFpg (M) (in which
the catalytic P1 of the enzyme was replaced by G1) were
Figure 1. Structure of abasic site substrate and analogues. Numbers in brackets correspond to the apparent dissociation constants (KD in nM) of EcFpg bound to
analogue-containing DNA measured by electrophoresis mobility shift assay. When indicated, the two numbers in brackets indicate the binding constants for the
EcFpg and LlFpg enzymes, respectively [
a(24);
b(25)]. AP site, abasic site; Pr, 1,3-propanediol; THF, tetrahydrofuran; rAP, reduced abasic site; Pyr, pyrolidine;
Cy, cyclopentane.
Table 1. DNA duplexes used in this study
DNA sequences DNA nomenclature
GCTCTTTXTTTCTC
CGAGAAACAAAGAG
8(X)
GCTCTTTXTTTCTC
GCGAGAAACAAAGA
8(X)
30
GCTCTTTXTTTCTC
GAGAAACAAAGAGC
8(X)
50
CTCTTTXTTTCTCG
GAGAAACAAAGAGC
7(X)
CTCTTTXTTTCTCG
CGAGAAACAAAGAG
7(X)
30
CTCTTTXTTTCTCG
AGAAACAAAGAGCG
7(X)
50
The DNA nomenclature convention is as followed: the first number indicated
the position from the 50 end of the AP site analogue in the damaged strand
and the letter (X) indicated the AP site analogue used (X ¼ Pr or THF). For
duplexes with sticky ends, the polarity of the overhang base is indicated
by 30 or 50.
Nucleic Acids Research, 2005, Vol. 33, No. 18 5937puriﬁed as described previously. Each protein (W or M) was
mixed with a 1.3 molar excess of DNA duplex to generate 24
protein/DNA complexes which were tested for systematic
crystallization.
Crystallization
The 12 P1G-LlFpg (M)/DNA complexes were crystallized at
room temperature by vapour diffusion with the hanging drop
method, using Crystal Screen 1 (Hampton Research). For the
initial crystallization trials, a 3 ml drop was prepared by mixing
1.5 ml of complex (5 mg/ml) with an equal volume of the
reservoir solution. Numerous crystals appeared within a few
daysin several conditions formostof the complexes. The most
promising results were obtained with the complexes M/7(Pr)
50
and M/7(THF)
50
with 1.4 M Sodium Citrate, 0.1 M Sodium
HEPES, pH 7.5. After optimization of these conditions (1.2–
1.6 M Sodium Citrate, 0.1 M Sodium HEPES, pH 7.5–8.5,
complex concentration: 2 mg/ml, complex/reservoir solution
ratio in the drop: 1/1 and 1/2), crystals of M/7(Pr)
50
and
M/7(THF)
50
complexes with dimensions 100 · 100 · 700
mm were obtained. Similar conditions were used to crystallize
the identical complexes named W/7(Pr)
50
and W/7(THF)
50
with the wild-type enzyme (W). All these complexes crystal-
lize in the tetragonal space group P41212, with cell dimensions
of a ¼ b ¼ 91 A ˚ and c ¼ 142 A ˚.
Data collection
Crystals selected for cryo-crystallographic experiments were
soaked in their crystallization buffer supplemented with 15%
glycerol as a cryo-protectant, before being ﬂash-cooled at
100K in a nitrogen gas stream. Diffraction data were collected
at the ID14 and BM30 beamlines at the ESRF (Grenoble,
France) to 1.8 and 1.9 A ˚ resolution for M/7(Pr)
50
and
M/7(THF)
50
complexes, respectively, and to 1.9 A ˚ resolution
for both W/7(Pr)
50
and M/7(THF)
50
complexes. Each dataset
was integrated with MOSFLM (27) and reduced by SCALA
(28). Conversion of I to F was performed using TRUNCATE.
Other calculations were carried out with the CCP4 program
suite (29). Detailed statistics are presented in Table 2.
Phasing and refinement
The structures of both complexes formed with P1G-LlFpg
(M/7(Pr)
50
and M/7(THF)
50
) were solved by the molecular
replacement method with the AMoRe program (30) using
the atomic coordinates of P1G-LlFpg enzyme (protein atoms
only) as the research model, [PDB code 1kfv, (16)] and dif-
fraction data comprised between 20 and 4 A ˚ resolution.
The best solution obtained after translation function search
corresponds to R-factors of 46.0 and 43.1% and correlation
coefﬁcients of 50.0 and 48.4%, respectively.
The whole reﬁnement was performed with the CNS pro-
gram (31). Prior to the reﬁnement process, 5% of the reﬂection
data were selected randomly and excluded from the reﬁnement
procedure (32). For each complex, the protein model was
submitted to a cycle of simulated annealing at 3000K followed
by some energy minimization cycles. At this stage, the elec-
tron density map indicated unambiguously the location of the
whole DNA molecule, which was added manually in the pro-
tein model using the O program (33). The atomic models were
then reﬁned further by energy minimization and atomic B-
factor reﬁnement. Zinc ion, glycerol, water molecules and
polypeptide regions that were missing in the initial model
were added progressively to the models during the reﬁnement
procedure. Further reﬁnement statistics are shown in Table 3.
The structures of the complexes formed with wt-LlFpg
(W/7(Pr)
50
and W/7(THF)
50
) were built in the electron density
map calculated after a step of rigid body reﬁnement of these
former models (REFMAC, (34)). The reﬁnement was then
conducted according to the same protocol.
Accession numbers. Atomic coordinates of these four models
have been deposited in the Protein Data Bank under the
accession codes 1NNJ [M/7(Pr)
50
], 1PJJ [M/7(THF)
50
], 1PJI
[W/7(Pr)
50
] and 1PM5 [W/7(THF)
50
].
RESULTS
General overview of the enzyme–DNA complexes
This work presents the crystal structures of the wild-type (W)
and the catalytic defective P1G-LlFpg mutant (M) bound to a
Table 2. Diffraction data
Enzyme P1G-LlFpg (M) Wild-type LlFpg (W)
Complex name M/7(Pr)
50
M/7(THF)
50
W/7(Pr)
50
W/7(THF)
50
Wave lengths (A ˚) 0.933 0.976
Beamline ID14 BM30
Parameters (A ˚) a ¼ b ¼ 92.1 c ¼ 142.5 a ¼ b ¼ 91.9 c ¼ 142.4 a ¼ b ¼ 91.9 c ¼ 142.1 a ¼ b ¼ 90.8 c ¼ 141.8
Space group P41212
Resolution (A ˚) 1.80 1.90 1.90 1.90
Unique reflections 56 858 48 703 48 727 43 717
Redundancy 11.6 9.6 2.5 6.7
Completeness (%) 97.6 100.0 99.2 97.5
hI/s(I)i 6.1 5.2 16.5 10.2
B-factor (A ˚ 2) (Wilson plot) 28.3 27.7 30.7 29.4
Rsym all data (last shell 0.074 (0.627) 0.073 (0.488) 0.062 (0.53) 0.045 (0.147)
Table 3. Refinement
Complex name M/7(Pr)
50
M/7(THF)
50
W/7(Pr)
50
W/7(THF)
50
PDB code 1NNJ 1PJJ 1PJI 1PM5
R.m.s.d. bond lengths 0.0050 A ˚ 0.0049 A ˚ 0.0055 A ˚ 0.0046 A ˚
R.m.s.d. bond angles 1.21  1.24  1.19 
hB-factori(A ˚ 2)
(DNA only)
31.0 (38.4) 31.0 (38.4) 34.5 (43.1) 30.9 (40.8)
Rfactor 0.215 0.202 0.210 0.196
Rfree (32) 0.236 0.220 0.237 0.216
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(Figure 1) AP site analogue named as M/7(Pr)
50
, M/7(THF)
50
,
W/7(Pr)
50
and W/7(THF)
50
(see the oligonucleotide nomen-
clature, Table 1).
Enzyme structure. These models were solved by the molecular
replacement method based on the previous model of P1G-
Ll-Fpg complexed to a 13mer DNA duplex containing a 1,3
propanediol nucleotide (16). The root-mean-square deviation
(r.m.s.d.) values calculated on the backbone Ca atoms of the
enzyme ( 0.15–0.5 A ˚) indicate that the enzyme Fpg adopts
a similar conformation in all ﬁve models independently of
the crystal packing and of the lesion type. These models
are also equivalent to the ones of Fpgs puriﬁed from other
organisms (Bacillus or Escherichia coli) and crystallized in
different conditions with other damaged bases and different
oligonucleotide sequences (17–19). The superposition with
these latter models leads to small r.m.s.d. as well ( 1.1 A ˚).
Similar to the other crystal structures of Fpg containing
an AP site (17,18), the aF-b9 loop connecting the H2TH
motif and the zinc ﬁnger is also partially disordered in all
these four models, independently of the lesion, of the oligo-
nucleotide sequence and length, and of the nature of the
enzymes (W or M).
DNAstructure.Thepresented models ofDNA–Fpgcomplexes
were crystallized with DNA duplexes harbouring 50 over-
hanging complementary bases (Table 1). Structural differ-
ences between these models and the previous structural
work result from the extremities of the DNA used in the
crystallization. 14mer duplexes with cohesive ends were con-
sidered in this present work while the ﬁrst model of LlFpg
complex was based on a 13mer duplex with blunt ends (16).
As previously described for the crystal structures of
Fpg-damaged DNA complexes, the oligonucleotide duplex,
globally structured as a B-DNA helix, is kinked towards the
major groove at the lesion site (16–20) (Figure 2). Extensive
contacts between Fpg residues and the damaged strand of
the duplex are responsible for this distortion of the DNA
helixaxis (16–20).TheDNA torsioniscentred onthe extruded
damaged nucleoside and stabilized by the intercalation in
the minor groove of three Fpg residues (M75, R109 and
F111 in Lactococcus lactis numbering) in the hole resulting
from the expulsion of the damage. Superimposition of the
four new structures with the P1G-LlFpg-13mer DNA com-
plex shows that the DNA torsion is similar for the 14mer
DNA duplexes ( 70 ) and for the 13mer DNA duplex
[ 60 ; CURVES, (35)] (Figure 3). This ﬁts well with the
bend observed in 16mer DNA duplex containing a reduced
AP site (rAP) bound by Fpg from Bacillus stearothermophilus
(18). The superposition of all DNA molecules used for these
structural studies shows that divergence on atomic positions
is larger at the oligonucleotides extremities than at the ﬁve
central nucleotides, centred on the damaged base (Figure 3).
In the vicinity of the extrahelical AP site where the enzyme
contacts the DNA backbone, the structure of the 13 and 14mer
bound duplexes superimpose perfectly independently of the
lesion type and/or the enzyme nature. Residues at the inter-
face between DNA and the enzyme have identical geometries
with respect to previous structural data. Therefore, the crystal
packing, the nucleotide sequence and the type of lesion
have little impact on speciﬁc protein–DNA interactions and
lesion recognition.
Fine structures of Pr- and THF-containing DNA
bound by mutant and wild-type Fpg
For both AP site analogues, the damaged nucleoside is ﬂipped
out off the DNA helix. At the lesion site, the B-DNA helical
Figure2.OverviewoftheFpg/DNAcomplex.(A)Ribbondiagramand(B)topologyofLlFpgboundtoDNA.Theribbonrepresentationcorrespondstothewild-type
LlFpg bound to the Pr site-containing 14mer DNA duplex [the complex named M/7(Pr)
50
, Tables 2 and 3]. LlFpg is constituted of an N-terminal domain (blue and
yellow), a C-terminal domain (red, orange and green) and two long loops (aG-aC and aF-b9). The N-terminal domain consists of a two-layered b-sandwich
includingthea-helicesA,BandG.TheC-terminaldomaincontainsthefoura-helicesC,D,EandF(redandorange)andtheb-hairpinloopb9–b10ofthezincfinger
(green). P1 which serves as a nucleophile in the glycosylase/lyase process points out on the protein surface toward the extrahelical damaged nucleoside at the
interphase between the two Fpg globular domains and DNA. b-strands and a-helices are represented by arrows and rectangles, respectively. The zinc atom
coordinatedbyfourcysteinesoftheFpgzincfingerisindicatedbyagreysphere.Thecolourcodefollowsthepreviousdefinitionoftheenzymedomains(16).DNA
atoms are represented by yellow ball-and-sticks. Figure generated by Molscript (41).
Nucleic Acids Research, 2005, Vol. 33, No. 18 5939parameters are strongly affected by the ﬂip-out and the local
compression of the phosphate-phosphate distance (Table 4). In
all structures, the AP site analogue is not directly contacted by
Fpg residues (Figure 4). The residue G1 adopts two alternative
conformations when the lesion is Pr but only one with THF.
In the THF/M complex, the amino group of G1 is 4.9 A ˚ away
of the C10 atom of the damage (Figure 4A). In the THF/W and
Pr/M complexes, the variation in position is restricted for
the catalytic residue P1, and the amino group of P1 and the
THF C10 atom are at VDW distances (3.5–4.3A ˚) (Figure 4B).
Figure 3. Structure of AP site analogue-containing DNA bound to Fpg. (A) Superposition of the DNA crystal structures. In magenta, Pr-containing the blunt
ended 13merDNA boundto theM enzyme
a(16)andin yellow,Pr-and THF-containing 14merDNA duplexesharbouringstickyends boundto theM orWenzyme
b(thiswork).(B)ZoomaroundtheDNAlesionforPr-andTHF-containing14merDNAduplexesboundtothewild-type(W)LlFpgenzyme.TheextrahelicalPrand
THF sites are painted in magenta and yellow, respectively. Largest atomic deviations between the two models are indicated. Figure generated by Pymol
(DeLano.http://www.pymol.org).
Table4.DNAbackbonetorsionanglesa,g andz ofAPsite-containingDNAboundbytheFpgproteinPr,THFandredAParefor1,3-propanediol,tetrahydrofuran
and reduced AP site, respectively
Protein–DNA complex Backbone torsion angles ( ) PDB ID code References
AP site DNA size (bp) Protein a (p
0–O
5 0
) g (C
4 0
–C
5 0
) z (O
3 0
–p
 1)
Pr 13 P1G-LlFpg  69.78  51.63  62.08 1KFV (16,26)
Pr 14 P1G-LlFpg  62.63  52.59  72.37 1NNJ This work
Pr 14 wt LlFpg  66.66  49.59  68.15 1PJI This work
THF 14 P1G-LlFpg 63.70  171.65  55.84 1PJJ This work
THF 14 wt LlFpg 63.71  174.63  56.76 1PM5 This work
rAP 16 wt BstFpg  157.90  65.71  62.27 1L1T (18)
Bold numbers highlight the torsion angle values of the THF site, which were significantly different from those of the other AP site analogues, Pr and rAP.
5940 Nucleic Acids Research, 2005, Vol. 33, No. 18Superposition of the four models shows that the mutation of
the N-terminal residue or the lesion type does not affect the
positions of the surrounding residues although THF is bigger
than Pr. The additional atoms of THF (C10,C 2 0 and O40)
are kept at VDW distances from the closest enzyme atoms.
In addition, the structures of the Pr and THF sites exhibit
conspicuous conformational differences, especially at the
phosphodiester backbone level of the target site (–C50–C40–
C30–) (Table 4 and Figure 3B). The THF nucleotide is there-
fore less extrahelical than the Pr site. The larger deviation
between these two AP sites concerns the C50 atoms (1.3 A ˚
displacement, Figure 3B). Superposition of the lesions bound
to the wild-type enzyme (W) and the P1G catalytic defective
mutant (M) does not exhibit major differences.
Superposition of our wild-type enzyme/THF- (or) Pr-DNA
complexes and with that of the reduced AP (rAP) site bound
to the B.stearothermophilus wild-type Fpg shows that the Pr
lesion gives the best ﬁt with rAP (18) (Figure 5). The extra-
helical position of rAP compares well with the one of the Pr
site. In the three complexes, the surrounding protein residues
adopt the same conformation except P1 that lies closer to
the rAP site. Amajor difference between these models consists
in the H-bond formed between the carboxylate group of E2
and the C40-OH group of rAP. Figure 6A also indicates that
Pr ﬁts better than THF to the 8-oxoG lesion in its complex
with the B.stearothermophilus E2Q-Fpg defective mutant
(19). The O8 atom of the 8-oxoG-containing DNA is replaced
by a solvent molecule conserved in all complexes of Fpg
bound to an AP site (Figure 6A). Position of the P1 residue
is also similar in the Fpg/Pr–DNA and Fpg/8–oxoG–DNA
complexes. With the FapyG containing structure (20), the
FapyG carbacycle occupies a position intermediate between
Pr and THF. FapyG is, however, less extrahelical. Distance
between the C60 atom of FapyG and the carboxylate group of
E2 is comparable with the equivalent distance in the THF
containing structures (Figure 6B).
DISCUSSION
The 3D structures of bound AP site analogues correlate
with functional studies
As compared with previous published crystal structures, the
four models we present in this study show that the interaction
of Fpg with a damaged nucleoside isindependent of the crystal
A
B
Figure 4. Superposition of the AP sites (THF and Pr). AP site-containing
DNA bound to (A) the P1G mutant enzyme and (B) to the wild-type enzyme.
Figure generated by Pymol (DeLano.http://www.pymol.org). Structures with
Pr and THF were painted in orange and in yellow, respectively.
Figure 5. Superposition of the THF and Pr binding site with the deoxyribose-
ringopenedrAPsite(17).THFinyellow;PrinorangeandrAPingreen.Figure
generated by Pymol (DeLano.http://www.pymol.org).
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lesion (16–20). All the structures of Fpg solved with an abasic
site-containing DNA exhibit similar protein:DNA interactions
and DNA torsions (16–18). The ﬁne differences concern the
geometry of the lesions (Pr or THF) and may explain the
difference in afﬁnity measured for each of these damaged
nucleosides. Indeed in previous studies, we have investigated
the AP site structural determinants required for a good recog-
nition (23,24) (Figure 1). We showed that among the AP site
analogues, THF was the least efﬁciently recognized by Fpg
and we proposed that this lower binding constant was due to
its heterocyclic oxygen which is negatively discriminated
by the enzyme. This hypothesis was supported by the fact
that the replacement of this oxygen atom (present in THF)
by a non-polar group (like a CH2-group in the carbocyclic
cyclopentanol AP site analogue, Cy, Figure 1) enhanced
Fpg binding 3- to 8-fold. Similar binding enhancement has
also been observed with several DNA glycosylases for the
positively charged pyrrolidine AP site analogue, Py, as com-
pared with THF (36,37) (Figure 1). All these functional data
have suggested that the hemiacetal form of the AP site was
better recognized by Fpg than the ring-closed forms and that a
negatively charged Fpg residue repulses the electronegative
heterocycle oxygen of THF. Our present structures conﬁrm
that the closer electronegative Fpg atoms belong to the strictly
conserved E2 residue (Figure 4). The E2 carboxyl side chain is
invariable whatever the lesion site or the source in the crys-
tallographic models (16–20). Interestingly, the OE2 carboxyl
group of E2 was shown to hydrogen bond the C40-OH group of
the rAP site analogue and of the Schiff base intermediate
(17,18) (Figure 5). Site-directed mutagenesis of E2 has also
shown that this residue is essential for Fpg activity (38). As a
matter of fact, the E2Q Fpg mutant was 2-fold less active than
the wild-type enzyme on an AP site-containing DNA used as
substrate. The hydrogen bond between E2 and the C40-OH of
the AP site ring-opened form would stabilize the sugar in its
acyclic form maintaining it in an optimal orientation for cata-
lysis. We had already anticipated this interaction comparing
the Fpg binding to rAP with other cyclic and non-cyclic AP
site analogues and suggested that the ring-opened aldehyde
tautomer of the AP site is the substrate active form for the Fpg
AP lyase activity (24). From the comparison of our structures
with those of rAP bound by Fpg and reduced Schiff base,
we can propose that the electronegative charge of the THF
heterocyclic oxygen is repulsed up to 3.8 A ˚ towards the DNA
major groove by the carboxyl group of E2, leading to signi-
ﬁcant structural changes of the THF phosphodiester back-
bone (Figure 5 and Table 4). These new structural data are
consistent with the less efﬁcient recognition of THF by Fpg
compared with the other designated AP site analogues (24,25).
This structural peculiarity of THF would also be related to its
mutagenic effects in vivo. Indeed, recent data suggested that a
very small structural difference in the AP site model (THF or
true AP site) inﬂuences the AP site mutagenic spectrum
greatly (39,40). Cytosine was most frequently incorporated
opposite a natural AP site (’C-rule’), followed by thymine.
In the case of THF, adenine, not cytosine, was mostfavourably
incorporated. These biochemical and functional studies have
also shown that THF blocks replication less than a natural
AP site. All these data suggest that THF and the true AP site
are not recognized in the same way by DNA polymerases. This
is also consistent with their recognition by Fpg.
Comparison between the recognition of the extruded
damaged base and the extruded AP site
If the cycle of THF is supposed to mimic the ﬂipped out
damaged base sugar after Fpg base excision (DNA glycosylase
activity), its C50 and C40 would not superpose with the Pr ones
(Figure 3A). Similar observations can be made comparing the
DNA backbone of THF with the one of the reduced abasic site
(rAP), the AP site analogue which is proposed to mimic better
the structure of the AP site immediately after the cleavage of
the damaged base N-glycosidic bond (18,24). The position
of the heterocyclic oxygen of THF was also signiﬁcantly
A
B
Figure 6. Superposition of AP sites with damaged nucleobase. (A) with the
8-oxoG (19) and (B) with the cFapyG (20). Figure generated by Pymol
(DeLano.http://www.pymol.org).
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opened which was hydrogen bound by the E2 residue
(Figure5). The restrainedcyclic form ofTHF seems to prevent
this site from adopting a perfect extrahelical conformation.
THF is less extruded from the DNA helix than Pr and rAP
sites (Figure 5). Contrary to THF, the Pr site considered as the
minimal AP site structure for Fpg-speciﬁc binding displays a
phosphodiester backbone which ﬁts nicely with that of rAP
(Figure 5). Recently, we have solved the structure of LlFpg
bound to a formamidopyrimidic residue analogue (cFapydG)
containing the same 14mer DNA duplex (Figure 6B) (20).
Similar to 8-oxodG, FapydG is a high efﬁciency Fpg substrate
(6). The orientation of the cyclopentane ring of cFapydG is
signiﬁcantly different from that of THF. Here again, THF
appears to be less extrahelical than cFapydG. The replacement
of the heterocyclic oxygen (present in the natural damaged
nucleoside and in THF) by a methyl group would explain this
observation. Indeed, the neutral group of the cyclopentane
of cFapydG is less repulsed by the OE2 carboxyl group of
E2 than the electronegative 40-heterocyclic oxygen of THF.
This assumption may be supported by the crystal structure of
Fpg from B.thermophilus [the E2Q defective mutant in DNA
glycosylase activity; (38)] bound to an 8-oxodG-containing
16mer DNA duplex (Figure 6A) (19). Similarly, the non-
electronegativity feature of Q2 abolishes the repulsion of
the heterocyclic oxygen of the 8-oxodG. Interestingly, the
structure of cyclopentane moiety of cFapydG ﬁts perfectly
with that of the deoxyribose of 8-oxodG. In addition, the
DNA backbone (C
50
–C
30
) at the lesion sites Pr, rAP, cFapydG
and 8-oxodG are very similar, while that of THF diverges
signiﬁcantly. As we proposed previously, the E2 residue
would collaborate with the nucleophile P1 residue to form
the imino enzyme–DNA intermediate (the transient N, N0-
disubstituted hemiaminal) in which the opening of the deox-
yribose ring associated to the damaged nucleoside occurs prior
to the cleavage of the N-glycosidic bond of the damaged base
(DNA glycosylase activity) (20,24). In the present
and previous models of Fpg bound to damaged DNA, the
observed angle of attack of the P1 nucleophile is highly
unfavourable for the N-glycosidic bond cleavage, suggesting
that initial step of catalysis would rather consist in the expul-
sion of the O40 leaving group, than in the cleavage of the
N-glycosidic bond (Figure 7). In this mechanistic model, E2
acts as a general acid catalyst for the DNA glycosylase pro-
cess, establishing a hydrogen bond with the C40-OH of the
deoxyribose-opened form. Finally, the hydrogen bond stabil-
izes the cationic Schiff base intermediate and sets the extra-
helical nucleosidic substrate in an optimal orientation for
the AP lyase process. This mechanistic model explains why
the rAP site is the very best Fpg high afﬁnity ligand (24) and
why the mutation E2Q is strongly deleterious for both Fpg
glycosylase and lyase activities (38).
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